prnewswire.comRevance and Teoxane Announce the FDA Approval of RHA Dynamic Volume for Midface Contour Deficiencies3 months ago
prnewswire.comRevance Announces Appointment of Steve Kreider as EVP, Chief Revenue Officer - Aesthetics and Therapeutics3 months ago
prnewswire.comRevance Announces Launch of New StriVectin TL Advanced Sculpting Neck & Jawline Mask4 months ago
prnewswire.comRevance Celebrates Distribution of One Million Vials of DAXXIFY in the U.S.7 months ago
prnewswire.comRevance Announces Launch of New PanOxyl Acne Gel Wash and Daytime Invisible Patches8 months ago
prnewswire.comRevance Announces Blue Lizard Australian Sunscreen Times Square Takeover to Celebrate National Sunscreen Day10 months ago
prnewswire.comRevance Announces Leadership Succession Plan to Support Next Phase of Growth and Innovation11 months ago
prnewswire.comRevance Announces Blue Lizard Australian Sunscreen Named the #1 Selling Mineral Sunscreen Brand11 months ago
CashuRevance Therapeutics Gains FDA Approval for RHA® Dynamic Volume in Aesthetic Treatments3 months ago
CashuRevance Therapeutics Appoints Steve Kreider as Chief Revenue Officer to Drive Growth.3 months ago
CashuRevance Therapeutics Appoints Steve Kreider as Chief Revenue Officer to Boost Growth Strategies3 months ago